U.S. Markets closed

Covidien authorizes new $3B share repurchase program

Covidien announced that its Board of Directors has authorized a new program to purchase up to $3B of the company’s ordinary shares from time to time, based on market conditions. This program is in addition to the $2B share repurchase program announced in August 2011, which currently has approximately $425M remaining.